nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—CYP1A1—chronic obstructive pulmonary disease	0.19	0.509	CbGaD
Quinine—CYP1A2—chronic obstructive pulmonary disease	0.183	0.491	CbGaD
Quinine—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.0912	0.199	CbGbCtD
Quinine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0515	0.112	CbGbCtD
Quinine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0338	0.0737	CbGbCtD
Quinine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0247	0.0538	CbGbCtD
Quinine—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0241	0.0527	CbGbCtD
Quinine—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0228	0.0497	CbGbCtD
Quinine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0182	0.0397	CbGbCtD
Quinine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0182	0.0397	CbGbCtD
Quinine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0164	0.0358	CbGbCtD
Quinine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0151	0.033	CbGbCtD
Quinine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0151	0.033	CbGbCtD
Quinine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0143	0.0311	CbGbCtD
Quinine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0138	0.0302	CbGbCtD
Quinine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0138	0.0302	CbGbCtD
Quinine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0123	0.0269	CbGbCtD
Quinine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0116	0.0253	CbGbCtD
Quinine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0115	0.025	CbGbCtD
Quinine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00784	0.0171	CbGbCtD
Quinine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00764	0.0167	CbGbCtD
Quinine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00747	0.0163	CbGbCtD
Quinine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00666	0.0145	CbGbCtD
Quinine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00652	0.0142	CbGbCtD
Quinine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00616	0.0134	CbGbCtD
Quinine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00391	0.00853	CbGbCtD
Quinine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00369	0.00805	CbGbCtD
Quinine—Quinidine—CYP1A1—chronic obstructive pulmonary disease	0.00101	0.509	CrCbGaD
Quinine—Quinidine—CYP1A2—chronic obstructive pulmonary disease	0.000971	0.491	CrCbGaD
Quinine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00241	CcSEcCtD
Quinine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000244	0.00241	CcSEcCtD
Quinine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000243	0.00241	CcSEcCtD
Quinine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.0024	CcSEcCtD
Quinine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.0024	CcSEcCtD
Quinine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000242	0.00239	CcSEcCtD
Quinine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00239	CcSEcCtD
Quinine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00239	CcSEcCtD
Quinine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00239	CcSEcCtD
Quinine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00239	CcSEcCtD
Quinine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00238	CcSEcCtD
Quinine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00237	CcSEcCtD
Quinine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00237	CcSEcCtD
Quinine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.00236	CcSEcCtD
Quinine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00235	CcSEcCtD
Quinine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000237	0.00234	CcSEcCtD
Quinine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00234	CcSEcCtD
Quinine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00233	CcSEcCtD
Quinine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00233	CcSEcCtD
Quinine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00232	CcSEcCtD
Quinine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00231	CcSEcCtD
Quinine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00023	0.00227	CcSEcCtD
Quinine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00226	CcSEcCtD
Quinine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00225	CcSEcCtD
Quinine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00224	CcSEcCtD
Quinine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00223	CcSEcCtD
Quinine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00222	CcSEcCtD
Quinine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00222	CcSEcCtD
Quinine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00221	CcSEcCtD
Quinine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000221	0.00219	CcSEcCtD
Quinine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00218	CcSEcCtD
Quinine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00218	CcSEcCtD
Quinine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00218	CcSEcCtD
Quinine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00217	CcSEcCtD
Quinine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00217	CcSEcCtD
Quinine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00214	CcSEcCtD
Quinine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00213	CcSEcCtD
Quinine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.0021	CcSEcCtD
Quinine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.0021	CcSEcCtD
Quinine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000212	0.0021	CcSEcCtD
Quinine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.00208	CcSEcCtD
Quinine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00207	CcSEcCtD
Quinine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00206	CcSEcCtD
Quinine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00206	CcSEcCtD
Quinine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00205	CcSEcCtD
Quinine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00203	CcSEcCtD
Quinine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00202	CcSEcCtD
Quinine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00202	CcSEcCtD
Quinine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00202	CcSEcCtD
Quinine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00202	CcSEcCtD
Quinine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00202	CcSEcCtD
Quinine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00202	CcSEcCtD
Quinine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00201	CcSEcCtD
Quinine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00201	CcSEcCtD
Quinine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.00201	CcSEcCtD
Quinine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00201	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00201	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00201	CcSEcCtD
Quinine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00198	CcSEcCtD
Quinine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00198	CcSEcCtD
Quinine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00197	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00197	CcSEcCtD
Quinine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00196	CcSEcCtD
Quinine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00195	CcSEcCtD
Quinine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00194	CcSEcCtD
Quinine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00194	CcSEcCtD
Quinine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00193	CcSEcCtD
Quinine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00191	CcSEcCtD
Quinine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00191	CcSEcCtD
Quinine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.00191	CcSEcCtD
Quinine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000193	0.0019	CcSEcCtD
Quinine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000192	0.0019	CcSEcCtD
Quinine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.0019	CcSEcCtD
Quinine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.0019	CcSEcCtD
Quinine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000192	0.0019	CcSEcCtD
Quinine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00189	CcSEcCtD
Quinine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00189	CcSEcCtD
Quinine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00188	CcSEcCtD
Quinine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00188	CcSEcCtD
Quinine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00188	CcSEcCtD
Quinine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.00188	CcSEcCtD
Quinine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00186	CcSEcCtD
Quinine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00186	CcSEcCtD
Quinine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00184	CcSEcCtD
Quinine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00183	CcSEcCtD
Quinine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00181	CcSEcCtD
Quinine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00181	CcSEcCtD
Quinine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.0018	CcSEcCtD
Quinine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.0018	CcSEcCtD
Quinine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00179	CcSEcCtD
Quinine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00179	CcSEcCtD
Quinine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00178	CcSEcCtD
Quinine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.00177	CcSEcCtD
Quinine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00177	CcSEcCtD
Quinine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00177	CcSEcCtD
Quinine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00177	CcSEcCtD
Quinine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00174	CcSEcCtD
Quinine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.00174	CcSEcCtD
Quinine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00173	CcSEcCtD
Quinine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00173	CcSEcCtD
Quinine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00173	CcSEcCtD
Quinine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00171	CcSEcCtD
Quinine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000172	0.0017	CcSEcCtD
Quinine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00017	0.00168	CcSEcCtD
Quinine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00167	CcSEcCtD
Quinine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00167	CcSEcCtD
Quinine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00167	CcSEcCtD
Quinine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00164	CcSEcCtD
Quinine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00163	CcSEcCtD
Quinine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00162	CcSEcCtD
Quinine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00161	CcSEcCtD
Quinine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00161	CcSEcCtD
Quinine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.0016	CcSEcCtD
Quinine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000162	0.0016	CcSEcCtD
Quinine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.0016	CcSEcCtD
Quinine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.0016	CcSEcCtD
Quinine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00159	CcSEcCtD
Quinine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00159	CcSEcCtD
Quinine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00158	CcSEcCtD
Quinine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00158	CcSEcCtD
Quinine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00158	CcSEcCtD
Quinine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00155	CcSEcCtD
Quinine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00154	CcSEcCtD
Quinine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00154	CcSEcCtD
Quinine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00153	CcSEcCtD
Quinine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00153	CcSEcCtD
Quinine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00153	CcSEcCtD
Quinine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00153	CcSEcCtD
Quinine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00153	CcSEcCtD
Quinine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00151	CcSEcCtD
Quinine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00151	CcSEcCtD
Quinine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.00151	CcSEcCtD
Quinine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00151	CcSEcCtD
Quinine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00151	CcSEcCtD
Quinine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000152	0.0015	CcSEcCtD
Quinine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.0015	CcSEcCtD
Quinine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000152	0.0015	CcSEcCtD
Quinine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000152	0.0015	CcSEcCtD
Quinine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.0015	CcSEcCtD
Quinine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00148	CcSEcCtD
Quinine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00148	CcSEcCtD
Quinine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00148	CcSEcCtD
Quinine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00145	CcSEcCtD
Quinine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00145	CcSEcCtD
Quinine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00145	CcSEcCtD
Quinine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00143	CcSEcCtD
Quinine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00143	CcSEcCtD
Quinine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00143	CcSEcCtD
Quinine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.00142	CcSEcCtD
Quinine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000142	0.0014	CcSEcCtD
Quinine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00139	CcSEcCtD
Quinine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00139	CcSEcCtD
Quinine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00137	CcSEcCtD
Quinine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00137	CcSEcCtD
Quinine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00137	CcSEcCtD
Quinine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00136	CcSEcCtD
Quinine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00135	CcSEcCtD
Quinine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00134	CcSEcCtD
Quinine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00133	CcSEcCtD
Quinine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00133	CcSEcCtD
Quinine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00131	CcSEcCtD
Quinine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000131	0.0013	CcSEcCtD
Quinine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00129	CcSEcCtD
Quinine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00129	CcSEcCtD
Quinine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00128	CcSEcCtD
Quinine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00128	CcSEcCtD
Quinine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00126	CcSEcCtD
Quinine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00125	CcSEcCtD
Quinine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00125	CcSEcCtD
Quinine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00123	CcSEcCtD
Quinine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00123	CcSEcCtD
Quinine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00122	CcSEcCtD
Quinine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00122	CcSEcCtD
Quinine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00122	CcSEcCtD
Quinine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00122	CcSEcCtD
Quinine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00121	CcSEcCtD
Quinine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00121	CcSEcCtD
Quinine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00121	CcSEcCtD
Quinine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00121	CcSEcCtD
Quinine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00121	CcSEcCtD
Quinine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000121	0.0012	CcSEcCtD
Quinine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000121	0.0012	CcSEcCtD
Quinine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00119	CcSEcCtD
Quinine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00117	CcSEcCtD
Quinine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00116	CcSEcCtD
Quinine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00116	CcSEcCtD
Quinine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00115	CcSEcCtD
Quinine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00115	CcSEcCtD
Quinine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00115	CcSEcCtD
Quinine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000117	0.00115	CcSEcCtD
Quinine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.00115	CcSEcCtD
Quinine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00115	CcSEcCtD
Quinine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00113	CcSEcCtD
Quinine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00113	CcSEcCtD
Quinine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00111	CcSEcCtD
Quinine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00109	CcSEcCtD
Quinine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00109	CcSEcCtD
Quinine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00108	CcSEcCtD
Quinine—KCNN4—bronchus—chronic obstructive pulmonary disease	0.000109	0.0921	CbGeAlD
Quinine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00107	CcSEcCtD
Quinine—KCNN4—smooth muscle tissue—chronic obstructive pulmonary disease	0.000106	0.0901	CbGeAlD
Quinine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00105	CcSEcCtD
Quinine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00103	CcSEcCtD
Quinine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00102	CcSEcCtD
Quinine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00101	CcSEcCtD
Quinine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000102	0.001	CcSEcCtD
Quinine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000996	CcSEcCtD
Quinine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.00097	CcSEcCtD
Quinine—KCNN4—trachea—chronic obstructive pulmonary disease	9.76e-05	0.0827	CbGeAlD
Quinine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.00094	CcSEcCtD
Quinine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.46e-05	0.000934	CcSEcCtD
Quinine—Erythema—Prednisone—chronic obstructive pulmonary disease	9.46e-05	0.000934	CcSEcCtD
Quinine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000881	CcSEcCtD
Quinine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.75e-05	0.000865	CcSEcCtD
Quinine—Agitation—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000859	CcSEcCtD
Quinine—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000854	CcSEcCtD
Quinine—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.00084	CcSEcCtD
Quinine—Syncope—Prednisone—chronic obstructive pulmonary disease	8.48e-05	0.000838	CcSEcCtD
Quinine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.44e-05	0.000834	CcSEcCtD
Quinine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.000821	CcSEcCtD
Quinine—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.00081	CcSEcCtD
Quinine—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000796	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8e-05	0.00079	CcSEcCtD
Quinine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.83e-05	0.000773	CcSEcCtD
Quinine—Oedema—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000763	CcSEcCtD
Quinine—Shock—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.00075	CcSEcCtD
Quinine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000748	CcSEcCtD
Quinine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.53e-05	0.000744	CcSEcCtD
Quinine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.000741	CcSEcCtD
Quinine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.000737	CcSEcCtD
Quinine—SLC22A4—respiratory system—chronic obstructive pulmonary disease	7.39e-05	0.0626	CbGeAlD
Quinine—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000727	CcSEcCtD
Quinine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000695	CcSEcCtD
Quinine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.02e-05	0.000694	CcSEcCtD
Quinine—KCNN4—lung—chronic obstructive pulmonary disease	7.01e-05	0.0594	CbGeAlD
Quinine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.71e-05	0.000663	CcSEcCtD
Quinine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.7e-05	0.000662	CcSEcCtD
Quinine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.69e-05	0.000661	CcSEcCtD
Quinine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.65e-05	0.000657	CcSEcCtD
Quinine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000628	CcSEcCtD
Quinine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000624	CcSEcCtD
Quinine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.31e-05	0.000623	CcSEcCtD
Quinine—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.13e-05	0.000606	CcSEcCtD
Quinine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.000603	CcSEcCtD
Quinine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.000603	CcSEcCtD
Quinine—SLC22A4—bronchus—chronic obstructive pulmonary disease	6.08e-05	0.0516	CbGeAlD
Quinine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.69e-05	0.000562	CcSEcCtD
Quinine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000547	CcSEcCtD
Quinine—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.46e-05	0.00054	CcSEcCtD
Quinine—SLC22A4—trachea—chronic obstructive pulmonary disease	5.46e-05	0.0463	CbGeAlD
Quinine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000522	CcSEcCtD
Quinine—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000504	CcSEcCtD
Quinine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000485	CcSEcCtD
Quinine—SLC22A5—respiratory system—chronic obstructive pulmonary disease	4.89e-05	0.0415	CbGeAlD
Quinine—Rash—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000481	CcSEcCtD
Quinine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.00048	CcSEcCtD
Quinine—Headache—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000478	CcSEcCtD
Quinine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.59e-05	0.000453	CcSEcCtD
Quinine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	4.43e-05	0.0376	CbGeAlD
Quinine—CYP1A1—respiratory system—chronic obstructive pulmonary disease	4.37e-05	0.037	CbGeAlD
Quinine—CYP3A5—respiratory system—chronic obstructive pulmonary disease	4.27e-05	0.0362	CbGeAlD
Quinine—SLC22A5—bronchus—chronic obstructive pulmonary disease	4.02e-05	0.0341	CbGeAlD
Quinine—CYP2E1—respiratory system—chronic obstructive pulmonary disease	3.99e-05	0.0338	CbGeAlD
Quinine—SLC22A4—lung—chronic obstructive pulmonary disease	3.92e-05	0.0333	CbGeAlD
Quinine—SLC22A5—trachea—chronic obstructive pulmonary disease	3.61e-05	0.0306	CbGeAlD
Quinine—SLCO1A2—lung—chronic obstructive pulmonary disease	3.6e-05	0.0305	CbGeAlD
Quinine—CYP1A1—bronchus—chronic obstructive pulmonary disease	3.6e-05	0.0305	CbGeAlD
Quinine—CYP1A1—trachea—chronic obstructive pulmonary disease	3.23e-05	0.0274	CbGeAlD
Quinine—SLC22A5—lung—chronic obstructive pulmonary disease	2.6e-05	0.022	CbGeAlD
Quinine—CYP1A2—lung—chronic obstructive pulmonary disease	2.35e-05	0.0199	CbGeAlD
Quinine—CYP1A1—lung—chronic obstructive pulmonary disease	2.32e-05	0.0197	CbGeAlD
Quinine—ABCB1—respiratory system—chronic obstructive pulmonary disease	2.27e-05	0.0192	CbGeAlD
Quinine—CYP3A5—lung—chronic obstructive pulmonary disease	2.27e-05	0.0192	CbGeAlD
Quinine—CYP2E1—lung—chronic obstructive pulmonary disease	2.12e-05	0.0179	CbGeAlD
Quinine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.07e-05	0.000323	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.06e-05	0.000322	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.99e-05	0.000311	CbGpPWpGaD
Quinine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.99e-05	0.000311	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.97e-05	0.000308	CbGpPWpGaD
Quinine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.96e-05	0.000307	CbGpPWpGaD
Quinine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.94e-05	0.000303	CbGpPWpGaD
Quinine—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.9e-05	0.000296	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.89e-05	0.000295	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.89e-05	0.000295	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.86e-05	0.00029	CbGpPWpGaD
Quinine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.86e-05	0.00029	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.85e-05	0.00029	CbGpPWpGaD
Quinine—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.85e-05	0.000289	CbGpPWpGaD
Quinine—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.000288	CbGpPWpGaD
Quinine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.83e-05	0.000286	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.83e-05	0.000285	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	1.81e-05	0.000283	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.81e-05	0.000282	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.8e-05	0.000282	CbGpPWpGaD
Quinine—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.78e-05	0.000278	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.75e-05	0.000274	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.74e-05	0.000272	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.74e-05	0.000272	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.00027	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.72e-05	0.000268	CbGpPWpGaD
Quinine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.71e-05	0.000267	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.7e-05	0.000266	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.69e-05	0.000264	CbGpPWpGaD
Quinine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.68e-05	0.000263	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.68e-05	0.000263	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.68e-05	0.000262	CbGpPWpGaD
Quinine—ABCB1—trachea—chronic obstructive pulmonary disease	1.68e-05	0.0142	CbGeAlD
Quinine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.62e-05	0.000253	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000251	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.6e-05	0.00025	CbGpPWpGaD
Quinine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000249	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000249	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.58e-05	0.000248	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.57e-05	0.000245	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.56e-05	0.000244	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.54e-05	0.000241	CbGpPWpGaD
Quinine—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.52e-05	0.000238	CbGpPWpGaD
Quinine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.46e-05	0.000229	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.45e-05	0.000227	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000226	CbGpPWpGaD
Quinine—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.44e-05	0.000224	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.43e-05	0.000224	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.42e-05	0.000222	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.00022	CbGpPWpGaD
Quinine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.000219	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.4e-05	0.000218	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.38e-05	0.000216	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000213	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.36e-05	0.000213	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000213	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000211	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.00021	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.32e-05	0.000206	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.31e-05	0.000204	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.3e-05	0.000204	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.3e-05	0.000203	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.3e-05	0.000203	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	0.000203	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.28e-05	0.0002	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.27e-05	0.000199	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.27e-05	0.000198	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.27e-05	0.000198	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.25e-05	0.000196	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000192	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000192	CbGpPWpGaD
Quinine—ABCB1—lung—chronic obstructive pulmonary disease	1.21e-05	0.0102	CbGeAlD
Quinine—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000188	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.2e-05	0.000188	CbGpPWpGaD
Quinine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.19e-05	0.000186	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.19e-05	0.000186	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.19e-05	0.000186	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.18e-05	0.000185	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.18e-05	0.000185	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.17e-05	0.000182	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000181	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.14e-05	0.000179	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000177	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000177	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.13e-05	0.000177	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.12e-05	0.000175	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.12e-05	0.000174	CbGpPWpGaD
Quinine—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000174	CbGpPWpGaD
Quinine—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000174	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.11e-05	0.000173	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.09e-05	0.00017	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.00017	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.06e-05	0.000165	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000165	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000164	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.04e-05	0.000162	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	0.000161	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.02e-05	0.000159	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.02e-05	0.000159	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.01e-05	0.000158	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.88e-06	0.000154	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.86e-06	0.000154	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.76e-06	0.000153	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	9.74e-06	0.000152	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	9.7e-06	0.000152	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.45e-06	0.000148	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.44e-06	0.000147	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.42e-06	0.000147	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.32e-06	0.000146	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.31e-06	0.000146	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.31e-06	0.000145	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.26e-06	0.000145	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.21e-06	0.000144	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.91e-06	0.000139	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	8.89e-06	0.000139	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.8e-06	0.000137	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.69e-06	0.000136	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.68e-06	0.000136	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.67e-06	0.000136	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.62e-06	0.000135	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.58e-06	0.000134	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.55e-06	0.000134	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.54e-06	0.000133	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.44e-06	0.000132	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.4e-06	0.000131	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.39e-06	0.000131	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.23e-06	0.000129	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	0.000128	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.21e-06	0.000128	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.19e-06	0.000128	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.16e-06	0.000127	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.08e-06	0.000126	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.05e-06	0.000126	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.87e-06	0.000123	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.8e-06	0.000122	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.74e-06	0.000121	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	7.7e-06	0.00012	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.66e-06	0.00012	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.62e-06	0.000119	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.59e-06	0.000119	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	7.53e-06	0.000118	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.44e-06	0.000116	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.35e-06	0.000115	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	7.13e-06	0.000111	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.1e-06	0.000111	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.02e-06	0.00011	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.01e-06	0.00011	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7e-06	0.000109	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.95e-06	0.000109	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.93e-06	0.000108	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	6.87e-06	0.000107	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	6.87e-06	0.000107	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.85e-06	0.000107	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.83e-06	0.000107	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.82e-06	0.000107	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.75e-06	0.000106	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.74e-06	0.000105	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.71e-06	0.000105	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.52e-06	0.000102	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.46e-06	0.000101	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.4e-06	0.0001	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.37e-06	9.95e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.33e-06	9.9e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.32e-06	9.88e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.3e-06	9.85e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.29e-06	9.83e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.28e-06	9.81e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.27e-06	9.79e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.26e-06	9.77e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.18e-06	9.66e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.96e-06	9.32e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.95e-06	9.3e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.94e-06	9.28e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.93e-06	9.27e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.92e-06	9.25e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.87e-06	9.17e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.84e-06	9.12e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.83e-06	9.1e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.78e-06	9.02e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.72e-06	8.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.69e-06	8.88e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	5.6e-06	8.75e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	8.73e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.47e-06	8.55e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.47e-06	8.55e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.44e-06	8.5e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.36e-06	8.37e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	5.35e-06	8.37e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.35e-06	8.35e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.28e-06	8.25e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.21e-06	8.14e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.21e-06	8.14e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.16e-06	8.06e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.16e-06	8.06e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.09e-06	7.95e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.08e-06	7.95e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.98e-06	7.79e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.86e-06	7.59e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.85e-06	7.59e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.82e-06	7.53e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.79e-06	7.49e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.75e-06	7.42e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.74e-06	7.4e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.6e-06	7.19e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.58e-06	7.16e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.53e-06	7.08e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.49e-06	7.02e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.46e-06	6.98e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.43e-06	6.92e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.23e-06	6.61e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.2e-06	6.56e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.18e-06	6.54e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.13e-06	6.46e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.12e-06	6.43e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.06e-06	6.34e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.05e-06	6.34e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.05e-06	6.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.99e-06	6.24e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.88e-06	6.06e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	3.87e-06	6.05e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.82e-06	5.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.81e-06	5.96e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.81e-06	5.95e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.78e-06	5.91e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.66e-06	5.71e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.59e-06	5.6e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.5e-06	5.48e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.38e-06	5.28e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.35e-06	5.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.21e-06	5.02e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.18e-06	4.96e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.13e-06	4.9e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.13e-06	4.89e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.06e-06	4.78e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.05e-06	4.77e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.99e-06	4.68e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.92e-06	4.56e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.92e-06	4.56e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.88e-06	4.5e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.85e-06	4.46e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.77e-06	4.32e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.75e-06	4.3e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.75e-06	4.29e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.73e-06	4.26e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.52e-06	3.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.47e-06	3.86e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.44e-06	3.81e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.33e-06	3.64e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.07e-06	3.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.9e-06	2.97e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.88e-06	2.94e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.8e-06	2.81e-05	CbGpPWpGaD
